Search results
New antibiotic based on AstraZeneca drugs kills off deadly bacteria, spares the good guys
FierceBiotech· 5 days agoA new antibiotic based on drugs developed by AstraZeneca can kill off dangerous bacteria that cause...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via AOL· 6 days agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
AstraZeneca’s breast cancer trial shows ‘unprecedented’ results | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 3 days agoAstraZeneca and Daiichi Sankyo’s Enhertu slows the progression of breast cancer by about five months...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 3 days agoStudy participants had already received one hormone therapy and a type of drug called a CDK 4/6...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Motley Fool via Yahoo Finance· 2 days agoAmgen is an established big pharma company with a massive pipeline and many avenues for growth...
AstraZeneca’s (AZN) “Buy” Rating Reaffirmed at Citigroup
ETF DAILY NEWS· 7 days agoCitigroup reissued their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a report published on Tuesday, Marketbeat reports. Several other analysts have also ...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 3 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 3 days agoBut what does June bring? Three Motley Fool contributors think the new month should usher in great investing opportunities. Here's why they picked AbbVie...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 3 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
Cramer's Lighting Round: 'You've got a winner' with Astra Zeneca
CNBC· 4 days ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...